KV9.3 Antibodies

Santa Cruz Biotechnology offers a broad range of KV9.3 monoclonal antibodies for research focused on understanding voltage-gated potassium channels. KV9.3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KV9.3, a member of the voltage-gated potassium channel family, plays a crucial role in regulating neuronal excitability and maintaining cellular homeostasis. Its function is vital in various physiological processes, including action potential propagation and neurotransmitter release. Understanding KV9.3 mechanisms can provide insights into neurological disorders and potential therapeutic targets. Research involving KV9.3 has revealed its significance in cellular signaling pathways and ion channel regulation. Investigating KV9.3 expression patterns helps researchers better understand neural circuit development and function. Exploring KV9.3 activity contributes to knowledge about membrane potential regulation and cellular communication. Santa Cruz Biotechnology monoclonal antibodies for KV9.3 enable researchers worldwide to advance neuroscience research and contribute to potential therapeutic developments.